| Evaluation of body-surface-area adjusted dosing of high-dose methotrexate by population pharmacokinetics in a large cohort of cancer patients U Arshad, M Taubert, T Seeger-Nukpezah, S Ullah, KC Spindeldreier, ... BMC cancer 21, 1-10, 2021 | 16 | 2021 |
| Prediction of exposure-driven myelotoxicity of continuous infusion 5-fluorouracil by a semi-physiological pharmacokinetic–pharmacodynamic model in gastrointestinal cancer patients U Arshad, S Ploylearmsaeng, MO Karlsson, O Doroshyenko, D Langer, ... Cancer chemotherapy and pharmacology 85, 711-722, 2020 | 16 | 2020 |
| Brain exposure to piperacillin in acute hemorrhagic stroke patients assessed by cerebral microdialysis and population pharmacokinetics S Ullah, R Beer, U Fuhr, M Taubert, M Zeitlinger, A Kratzer, C Dorn, ... Neurocritical Care 33, 740-748, 2020 | 11 | 2020 |
| A population pharmacokinetic model of intravenous telavancin in healthy individuals to assess tissue exposure S Ullah, P Matzneller, M Zeitlinger, U Fuhr, M Taubert Naunyn-Schmiedeberg's Archives of Pharmacology 392, 1097-1106, 2019 | 5 | 2019 |
| Pharmacokinetics of metronomic temozolomide in cerebrospinal fluid of children with malignant central nervous system tumors S Büsker, W Jäger, S Poschner, L Mayr, V Al Jalali, J Gojo, AA Azizi, ... Cancer Chemotherapy and Pharmacology 89 (5), 617-627, 2022 | 2 | 2022 |
| A model‐based approach to assess unstable creatinine clearance in critically ill patients S Ullah, M Zoller, U Jaehde, M Huseyn‐Zada, T Weig, U Fuhr, U Arshad, ... Clinical Pharmacology & Therapeutics 110 (5), 1240-1249, 2021 | 2 | 2021 |
| A teaching tool about the fickle p value and other statistical principles based on real-life data S Alawbathani, M Batool, J Fleckhaus, S Hamad, F Hassenrück, Y Hou, ... Naunyn-schmiedeberg's Archives of Pharmacology 394, 1315-1319, 2021 | 1 | 2021 |
| Population pharmacokinetics of meropenem in patients undergoing automated peritoneal dialysis S Ullah, M Ursli, U Fuhr, M Wiesholzer, M Kussmann, W Poeppl, ... Peritoneal Dialysis International 43 (5), 402-410, 2023 | | 2023 |
| Cefepime Population Pharmacokinetics, Antibacterial Target Attainment, and Estimated Probability of Neurotoxicity in Critically Ill Patients MT Muhammad Bilal 1 2, Michael Zoller 3, Uwe Fuhr 1, Ulrich Jaehde 2, Sami ... Antimicrob Agents Chemother ., 2023 | | 2023 |
| Development of a population pharmacokinetic covariate model of rifampicin in healthy Caucasian volunteers M Bilal, S Ullah, C Trueck, B Wachall, M Wargenau, B Scheidel, ... EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 78 (SUPPL 1), S110-S110, 2022 | | 2022 |
| Frequency and Susceptibility Pattern of Pseudomonas aeruginosa in Pus Samples MA Jamshaid S, Afsheen Z, Hussain MM, Ali G, Ishaq MS, Ullah S Khyber Journal of Medical Sciences (KJMS) 6, 155-157, 2013 | | 2013 |
Uwe FuhrUniversity of CologneVerified email at uk-koeln.de
